AnaptysBio, Inc. (ANAB) vs Certara, Inc. (CERT)
A side-by-side comparison of AnaptysBio, Inc. and Certara, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANAB
AnaptysBio, Inc.
$47.89HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
CERT
Certara, Inc.
$9.21HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — ANAB vs CERT
growth of $100 · dividends reinvested · last 6yANAB +213.6% (+21.0%/yr)CERT -73.6% (-19.9%/yr)ANAB compounded faster over this window
Log scale — wide-divergence pair
ANAB CERT
ANAB vs CERT: by the numbers
- •CERT is the larger company ($1.43B vs $1.42B market cap).
- •ANAB is profitable (82.37% net margin) while CERT runs a net loss (-16.75%).
- •ANAB grew revenue faster over the past five years (18.60% vs 9.31% CAGR).
Metrics side by side
Valuation
| Metric | ANAB | CERT |
|---|---|---|
| P/E ratio | 8.92 | N/A |
| Forward P/E | N/A | 27.05 |
| P/S ratio | 5.97 | 3.51 |
| P/B ratio | 133.97 | 1.48 |
| EV / EBITDA | 11.45 | 26.09 |
| FCF yield | 1.27% | 4.30% |
Profitability
| Metric | ANAB | CERT |
|---|---|---|
| Gross margin | 98.97% | 58.33% |
| Operating margin | 20.42% | 1.86% |
| Net margin | 82.37% | -16.75% |
| ROE | 1849.06% | -7.08% |
| ROIC | 47.55% | 0.59% |
Growth (annualized)
| Metric | ANAB | CERT |
|---|---|---|
| Revenue CAGR (5Y) | 18.60% | 9.31% |
| FCF CAGR (5Y) | 27.41% | 8.78% |
| Total return CAGR (5Y) | 21.54% | -21.31% |
Frequently asked
- Which has grown faster, ANAB or CERT?
- Over the past five years, ANAB grew revenue faster — ANAB at a 18.60% CAGR versus CERT at 9.31%.
- Is ANAB or CERT more profitable?
- ANAB runs the higher net margin — ANAB at 82.37% versus CERT at -16.75%.
- How have ANAB and CERT total returns compared?
- Over the past 5 years, ANAB delivered 21.54% and CERT delivered -21.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AnaptysBio P/E ratioAnaptysBio ROECertara ROEAnaptysBio operating marginCertara operating marginAnaptysBio revenue growthCertara revenue growthAnaptysBio free cash flowCertara free cash flow
AnaptysBio & Certara appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.